Form 8-K - Current report:
SEC Accession No. 0000200406-22-000076
Filing Date
2022-09-14
Accepted
2022-09-14 07:10:20
Documents
14
Period of Report
2022-09-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20220914.htm   iXBRL 8-K 49358
2 EX-99.1 final_sharebuybackprx91322.htm EX-99.1 8504
  Complete submission text file 0000200406-22-000076.txt   262472

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20220914.xsd EX-101.SCH 3326
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20220914_def.xml EX-101.DEF 16756
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20220914_lab.xml EX-101.LAB 34197
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20220914_pre.xml EX-101.PRE 17558
8 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20220914_htm.xml XML 19054
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 221242068
SIC: 2834 Pharmaceutical Preparations